Condition

Cardiomyopathies, Secondary

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.NCT04654988 · 2022-12-01

ACTIVE_NOT_RECRUITING

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral NeuropathyNCT04985734 · 2021-10-01

UNKNOWN

The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. PredictorNCT03505164 · 2017-01-17

COMPLETED

Common interventions

AzathioprineDRUG1Placebo AzathioprineDRUG1Placebo PrednisoneDRUG1PrednisoneDRUG1Specific diagnostic work-up for ATTR-CM patientsDIAGNOSTIC_TEST1

Leading sponsors

Medical University of Warsaw1Rush University Medical Center1University Hospital, Antwerp1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

UNKNOWN1

Phase mix

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.